(Reuters) - A former executive at pharmaceutical company InterMune Inc and a British restaurant owner were found liable on Monday on U.S. civil charges that they engaged in a $1 million insider ...
BRISBANE, Calif., March 2, 2010 /PRNewswire via COMTEX/ -- InterMune, Inc. (Nasdaq: ITMN) today announced that it has submitted a Marketing Authorization Application (MAA) to the European Medicines ...
Intermune stock falls on warning / Brisbane biotech firm scales back sales projections for lung drug
Intermune Inc. shares lost a third of their value Thursday after the Brisbane biotechnology firm said it had over-estimated the revenues it expects from its lead drug in 2003 by as much as $30 million ...
InterMune has agreed to pay federal and state governments more than $36.9 million to settle charges it illegally promoted its immune systems disorder drug Actimmune. The federal government charged the ...
Can a Bay Area biotech firm make money buying hand-me-down drugs? InterMune hopes the answer is yes. Yesterday the Brisbane firm bought the fourth in a series of medicines developed by big outfits ...
InterMune to Cut 50 Percent of Staff, Withdraws 2007 Rev View BRISBANE, Calif., March 20 -- InterMune, Inc. today announced that it has completed a review of its research and development programs and ...
BERLIN (AP) — Swiss pharmaceutical company Roche said Sunday it has reached an $8.3 billion deal to buy InterMune, a California-based developer of treatments for lung diseases. The companies have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results